Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Chronic plaque, guttate and flexural psoriasis

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Unstable widespread psoriasis

Generalised pustules or near-total skin inflammation with fever, malaise, shivering, dehydration or circulatory compromise can represent generalised pustular psoriasis or erythroderma.

Action: Assess ABCDE and observations, stop non-essential possible triggers, and arrange immediate same-day specialist assessment; do not manage systemic upset as an ordinary plaque flare.

Synopsis

Distinguish three common psoriasis phenotypes, assess severity and whole-person impact, recognise instability, and choose site-appropriate first treatment and referral without relying on erythema alone.

  • Chronic plaque psoriasis produces persistent, well-demarcated scaly plaques, classically on extensor elbows and knees, scalp, sacrum and umbilicus; colour may be red, violaceous, brown or grey according to skin tone.
  • Guttate psoriasis is an acute shower of small scaly papules, often one to three weeks after streptococcal pharyngitis; inspect the throat but do not promise that antibiotics will clear the eruption.
  • Flexural psoriasis is smooth, sharply bordered and minimally scaly in axillae, groin, inframammary folds or natal cleft; exclude candidiasis, dermatophyte infection and contact irritation when atypical.
  • Record patient and clinician global severity, body surface area, difficult sites, nail disease, systemic upset, life impact and joint symptoms; erythema can be underestimated in deeply pigmented skin.
  • Topical treatment is first-line for most limited disease, but formulation and potency must follow site: thick trunk plaques tolerate different therapy from face, flexures and genitals.
  • Refer for diagnostic uncertainty, more than 10% body surface area, inadequate topical control, major functional or psychosocial impact, phototherapy need, significant nails, or any childhood psoriasis.
  • Generalised pustular psoriasis or erythroderma requires immediate same-day specialist assessment, while suspected psoriatic arthritis requires rheumatology referral as soon as it is recognised.
  • Ask about smoking, alcohol, weight, cardiovascular risk, mood and treatment practicality without implying blame; agree goals that matter to the person.

Key red flags

Diffuse tender erythema, sterile-looking pustules, fever, malaise, shivering, oedema, dehydration or altered observations require same-day specialist care.

A hot swollen joint, dactylitis, inflammatory back pain or painful enthesitis suggests psoriatic arthritis and needs prompt rheumatology assessment.

Rapid change after starting or stopping a medicine, especially systemic corticosteroid withdrawal, requires a full medication timeline and urgent advice if disease is unstable.

Major mood disturbance, hopelessness or self-harm thoughts are clinical severity markers and require direct risk assessment and appropriate urgent mental-health support.

Joint warning symptoms

Morning stiffness, swollen joints, whole-digit swelling, heel pain or inflammatory back pain can precede or follow cutaneous disease. A negative PEST does not exclude axial arthritis or inflammatory back pain.

Systemic instability

Fever, malaise, widespread pustulation, rapidly spreading erythema, oedema, shivering or reduced urine output are not routine plaque symptoms. Check observations and arrange same-day specialist assessment.

Investigation priorities

01
First assessment: morphology and full skin examinationFirst step

Establish plaque, guttate or flexural phenotype and detect scalp, nail, palmoplantar or genital involvement.

Management branches

First-lineLimited chronic plaques on trunk or limbs

Adult plaque psoriasis amenable to topical treatment and without unstable features.

  1. Agree a formulation the person can use, demonstrate fingertip-unit quantities, and use emollient or soap substitute to soften scale while explaining fabric fire risk.
  2. Use a potent topical corticosteroid once daily plus a vitamin-D analogue once daily, applied separately morning and evening, for up to four weeks as NICE initial trunk-and-limb treatment.
  3. Review response, adherence, quantity, irritation and steroid adverse effects by four weeks; do not automatically continue potent steroid beyond the planned course.
  4. If goals are unmet, follow the NICE topical sequence or refer when extent, difficult site, distress or repeated failure makes topical-only care inadequate.

Key medicines

Potent topical corticosteroid plus vitamin-D analogueApply the potent corticosteroid thinly once daily and the vitamin-D analogue once daily at a different time, one in the morning and one in the evening, for up to 4 weeks.Keep each product within its licence and prescribed quantity; avoid potent steroid on face, flexures or genitals, monitor atrophy, and respect vitamin-D analogue area and dose limits.
Mild or moderate potency topical corticosteroid for sensitive sitesApply a thin layer once or twice daily to affected face, flexural or genital skin for no longer than 2 weeks, using the prescribed potency and quantity.Do not substitute a potent or very potent product; reassess persistent disease for infection, contact allergy or an alternative diagnosis, and avoid indefinite repeat courses without review.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE CG153: psoriasis assessment and management recommendations
  • British Association of Dermatologists: psoriasis overview
  • British Association of Dermatologists: topical treatments for psoriasis
  • MHRA: safe use of emollient skin creams

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom